Fetal Lung Maturity Testing And Neonatal Respiratory Complications In Women With Type 1 Diabetes Mellitus Electively Delivered Before 39 Weeks Gestation
Journal of Women's Health Care

Journal of Women's Health Care
Open Access

ISSN: 2167-0420


Research Article - (2012) Volume 1, Issue 3

Fetal Lung Maturity Testing And Neonatal Respiratory Complications In Women With Type 1 Diabetes Mellitus Electively Delivered Before 39 Weeks Gestation

Gary Ventolini1*, Britta Buchenroth2, Kelly McCluskey1, Marc R. Belcastro3, Daniel L. Hood4 and Ran Neiger1
1omi_departments of Obstetrics and Gynecology, Wright State University, Boonshoft School of Medicine, Miami Valley Hospital; Dayton, Ohio, USA
2Medical School, Wright State University, Boonshoft School of Medicine, Miami Valley Hospital; Dayton, Ohio, USA
3Neonatal Intensive Care Unit, Miami Valley Hospital, Dayton, Ohio, USA
4Department of Pathology, Miami Valley Hospital, Dayton, Ohio, USA
*Corresponding Author: Gary Ventolini, omi_departments of Obstetrics and Gynecology, Wright State University, Boonshoft School Of Medicine, Miami Valley Hospital; Dayton, Ohio, USA Email:


The American College of Obstetricians and Gynecologists (ACOG) recommends documentation of fetal lung maturity when a delivery is performed before 39 weeks gestation [1]. Despite adherence to the ACOG guidelines preventable morbidity continues to occur in women delivered before 39 weeks gestation. Although the false positive rate of fetal lung maturity tests is very low, it may account for some of the cases where despite tests that had suggested mature lungs neonates develop respiratory complications after delivery. The risk for such complications is higher in newborns delivered by cesarean section [2] and in those delivered to mothers with diabetes [3]. It is therefore important to evaluate the occurrence of neonatal respiratory complications among babies born before 39 weeks after fetal lung maturity had been documented, especially among women with type 1 DM.

The purpose of this study was to evaluate the rate of neonatal respiratory complications among neonates delivered to women with type 1 DM who underwent elective cesarean deliveries before 39 weeks gestation after documentation of fetal lung maturity, compared to neonates born to similar women after 39 weeks. We elected to study only neonates delivered by cesarean sections because these newborns were at a higher risk of developing respiratory complications than newborns delivered vaginally [2]. In addition, we wanted to minimize the possibility that variables associated with vaginal delivery (e.g. length and mode of induction, risk of chorioamnionitis, instrumental delivery etc.) may contribute to the respiratory complications we studied.

Materials and Methods

The study population included a cohort of neonates delivered by elective cesarean section to women with type 1 DM before 39 weeks gestation after documentation of fetal lung maturity by amniotic fluid analysis. All deliveries took place at Miami Valley Hospital in Dayton, Ohio between January 1, 2004 and December 31, 2008. Indications for fetal lung maturity testing included: scheduled repeat cesarean section due to previous classical uterine incision or history of uterine incision extension, suspected fetal macrosomia (defined as equal or above 4,500g), or inadequate glycemic control (fasting blood sugar values ≥ 95 mg/dl or blood sugar values that were repeatedly ≥ 140 mg/dl or ≥ 120 mg/dl one or two hours after meals, respectively) with suspected fetal macrosomia and polyhydramnios. The algorithm used to assess fetal lung maturity is described in Figure 1 [4]. The cutoffs used to define lung maturity were not altered for maternal diabetes (lamellar body count cutoff of 50,000; for Fetal Lung Maturity test (FLM III): 55, and Lecithin/Sphingomyelin ratio: 2.0) [5,6]. Neonatal outcome parameters included Apgar scores at 5 minutes, umbilical cord blood gases, birth weight, need for respiratory assistance at birth, admission to the Neonatal Intensive Care Unit (NICU) due to respiratory complications (e.g. episodes of apnea, requirement of oxygen, ventilation or CPAP), and delay in hospital discharge due to Respiratory Related Symptoms (RRS) defined as hospital stay longer than 96 hours after the c-section.


Figure 1: Lamellar body count algorithm.

The control group consisted of neonates delivered by elective caesarean section at the same hospital during the same period after 39 weeks gestation without fetal lung maturity studies to women with type 1 DM. The women were similar by age, race, gravidity and parity, duration of maternal diabetes, and insulin requirement. Similar neonatal outcome parameters were assessed in the control group.

Statistical analysis was performed using Graphpad Software (Graphpad Software, Inc., San Diego, California); we used two tailed t-tests for continuous data and/or chi-square analysis for proportions. A p value of less than 0.05 was considered significant. The study was approved by the Institutional Review Board.


The study population included 95 women with type 1 DM who underwent amniocentesis for fetal lung maturity studies at 37±1 weeks gestation. Seventy eight lung maturity tests (82.1%) suggested maturity and these women underwent elective cesareans. Seventeen tests (17.9%) suggested immaturity; these women were retested one week later, at an average gestational age of 38±2 weeks; all tests suggested maturity and the women were delivered.

All deliveries were by cesarean sections. The indications for surgery were: 45 repeat cesarean sections (47.4%), 12 breech presentations (12.6%), 12 women had poor glycemic control (12.6%), 10 with estimated fetal weight over 4,500 g (10.5%), seven had 4th degree perineal tear during previous delivery (7.4%), seven were done at patients request (7.4%) and two had low cervical leiomyomas (2.1%). The indications for cesarean delivery in the control group were comparable to the study group.

Seven of the 78 neonates (9%) whose lung maturity studies were mature at the time of the first amniocentesis required admission to the Neonatal Intensive Care Unit (NICU) due to respiratory complications. Five additional neonates from this group (6.4%) required respiratory assistance at birth. The overall neonatal respiratory complication rate in the group of women delivered after the first amniocentesis was 15.4%, and the rate for the entire study group of 95 women was 12.6%. The hospital discharge of six of the study group’s neonates was delayed due to RRS. The number of respiratory complications in the control group was four of 94 (4.3%) (P=0.0001) (Table 1).

COMPLICATIONS Study group controls
Number 95 94
NICU admissions 7 (7.4%) 2 (2.1%)
Respiratory assistance 5 (5.3%) 2 (2.1%)
Overall respiratory complication 12 (12.6%) 4 (4.3%)
Delayed hospital discharge 6 (6.3%) 1 (1.1%)

Table 1: Neonatal Complications.


In 1996 ACOG’s published the recommendation to confirm fetal maturity before elective delivery prior to 39 weeks gestation [1]. The validity of this recommendation was demonstrated in recent studies. Stutchfield et al. [7] reported in 2005 that delaying cesarean deliveries until 39 weeks gestation reduced the rate of admissions to neonatal special care units due to respiratory distress [7]. However, even when the ACOG’s recommendation is followed and fetal lung maturity is documented prior to delivery, a small number of newborns delivered by elective deliveries before 39 weeks gestation develop respiratory complications. The risk of such complications is increased among babies delivered early by planned cesarean section since cesarean delivery is associated with an increased risk of neonatal respiratory complications compared with vaginal delivery. Recently Kamath et al. [2] conducted a retrospective study on neonatal outcomes after elective cesarean delivery and reported significantly higher rates of respiratory morbidity, NICU admissions, and longer hospital stay compared to vaginal birth after cesareans.

The positive predictive value of fetal lung maturity tests is over 95%, [1] however, some test results can be falsely positive. Women with diabetes, especially when poorly controlled, may have delayed fetal lung maturation, an increased risk of false fetal lung maturity test results, or both [1]. In 2002, Moore postulated that fetal pulmonary maturation, as evidenced by the onset of posphatidylglycerol production in the amniotic fluid, is delayed in pregnancy complicated by maternal diabetes by 1 to 1.5 weeks [3]. The possibility of false positive test results may be even higher in pregnancies complicated by pre-pregnancy diabetes. The risk of a false positive test may be minimized by avoiding fetal lung maturity all together: in a recent study, Kjos et al. [8] studied the rate of Respiratory Distress Syndrome (RDS) among newborns of diabetic mothers and concluded that routine FLM testing did not change the prevalence of RDS when pregnancies were reliably dated, and suggested that such testing be abandoned. They also reported that cesarean delivery was associated with an increased rate of RDS [8].

It is possible that the method we used for assessing fetal lung maturity in these women was responsible for the relatively high number of newborns with respiratory complications. The algorithm we used for testing fetal lung maturity was previously described in an earlier study [4]. It was based on a consensus protocol published by Neehof and his associates in 2001 [5]. We previously reported that employing this algorithm for analyzing amniotic fluid samples resulted in a significant monetary saving [9]. Recently Janicki et al. [6] questioned the 50,000 lamellar body count thresholds and demonstrated the need for hematology analyzer specific thresholds.

This was a retrospective cohort study conducted at a single tertiary care center; nevertheless, it raises concern regarding elective cesarean deliveries performed prior to 39 weeks gestation, especially in women with type 1 DM. Similar findings were recently reported by Kamath et al. [2] who conducted a retrospective study of neonatal outcomes among non-diabetic mothers who underwent elective cesarean delivery. They observed significantly higher rates of respiratory morbidity, NICU admissions and longer length of hospital stay compared with newborns delivered vaginally [2]. It should be noted that we did not study other potential neonatal complications that may also develop in immature neonates.

Providing appropriate medical care limits physical and emotional hardship to newborns and their families and contributes to patient’s satisfaction. The financial savings associated with avoidance of costs associated with prolonged care and delayed hospital discharge is an additional benefit.


Preventing adverse neonatal outcomes is one of the higher priorities of obstetric care. Our findings emphasize the importance minimizing the number of elective cesarean deliveries prior to 39 weeks gestation, especially in women with pre-pregnancy diabetes mellitus.


  1. ACOG (1996) American College of Obstetrics and Gynecology ACOG. Educational Bulletin.
  2. Kamath BD, Todd JK, Glazner JE, Lezotte D, Lynch AM (2009) Neonatal outcomes after elective cesarean delivery. Obstet Gynecol 113: 1231-1238.
  3. Moore TR (2002) A comparison of amniotic fluid fetal pulmonary phospholipids in normal and diabetic pregnancy. Am J Obstet Gynecol 186: 641-650.
  4. Ventolini G, Neiger R, Hood D, Belcastro C (2005) Update on assessment of fetal lung maturity. J Obstet Gynaecol 25: 535-538.
  5. Neerhof MG, Dohnal JC, Ashwood ER, Lee IS, Anceschi MM (2001) Lamellar body counts: a consensus on protocol. Obstet Gynecol 97: 318-320.
  6. Janicki MB, Dries LM, Egan JF, Zelop CM (2009) Determining a cutoff for fetal lung maturity with lamellar body count testing. J Matern Fetal Neonatal Med 22: 419-422.
  7. Stutchfield P, Rhiannon W, Russell I (2005) On behalf of the Antenatal Steroids for Term Elective Cesarean Section ( ASTECS ) Research Team. BMJ 1-6.
  8. Kjos SL, Berkowitz KM, Kung B (2002) Prospective delivery of reliably dated term infants of diabetic mothers without determination of fetal lung maturity: comparison to historical control. J Matern Fetal Neonatal Med 12: 433-437.
  9. Ventolini G, Neiger R, Hood DL, Belcastro MR (2006) Changes in the threshold of fetal lung maturity testing and neonatal outcome of infants delivered electively before 39 weeks gestation: implications and cost-effectiveness. J Perinatol 26: 264-267.
Citation: Ventolini G, Buchenroth B, McCluskey K, Belcastro MR, Hood DL, et al. (2012) Fetal Lung Maturity Testing and Neonatal Respiratory Complications in Women with Type 1 Diabetes mellitus Electively Delivered before 39 Weeks Gestation. J Women’s Health Care 1:111.

Copyright: © 2012 Ventolini G, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.